Innovative Pharma Solutions Inc is categorized under Business Consultants in Ambler, PA and active since 2010.
Innovative Pharma Solutions Inc was established in 2010, and today employs 1 to 4, earning $50.000 to $99.999 per year. This is a Business Consultants business, which does work in the B2B market, and is classified as a Business Consultants, under code number 541618 by the NAICS.
If you are seeking more information, feel free to contact Steven Choi at the company’s single location by writing to 780 Brushtown Road, Ambler, Pennsylvania PA 19002 or by phoning (610) 517-0748. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Innovative Pharma Solutions Inc |
| Contact Person: | Steven Choi |
| Address: | 780 Brushtown Road, Ambler, Pennsylvania 19002 |
| Phone Number: | (610) 517-0748 |
| Annual Revenue (USD): | $50.000 to $99.999 |
| Founded: | 2010 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Business Consultants |
| SIC Code: | 8748 |
| NAICS Code: | 541618 |
| Share This Business: |
Innovative Pharma Solutions Inc was started in 2010 to provide professional Business Consultants under the SIC code 8748 and NAICS code 541618. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $50.000 to $99.999 per annum.
Feel free to contact Steven Choi for inquiries that concern Innovative Pharma Solutions Inc by calling the company number (610) 517-0748, as your correspondence is most welcome. Additionally, the physical location of the single location of Innovative Pharma Solutions Inc can be found at the coordinates 40.184217,-75.245578 as well as the street address 780 Brushtown Road in Ambler, Pennsylvania 19002.
For its online presence, you may visit Innovative Pharma Solutions Inc’s website at and engage with its social media outlets through on Twitter and on Facebook.